Translocation Carcinomas of the Kidney
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hemesath, T. J., Steingrímsson, E., McGill, G., Hansen, M. J., Vaught, J., Hodgkinson, C. A., Arnheiter, H., Copeland, N. G., Jenkins, N. A., & Fisher, D. E. (1994) · Genes & Development · doi:10.1101/gad.8.22.2770 · Cited by 673
Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma
Argani, P., Antonescu, C. R., Illei, P. B., Lui, M. Y., Timmons, C. F., Newbury, R., Reuter, V. E., Garvin, A. J., Perez-Atayde, A. R., Fletcher, J. A., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61684-7 · Cited by 643
Self-citationArgani, P., Lal, P., Hutchinson, B., Lui, M. Y., Reuter, V. E., & Ladanyi, M. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200306000-00005 · Cited by 627 · cited 2×
“1C, 2D) [20].”
BackgroundSelf-citationLadanyi, M., Lui, M. Y., Antonescu, C. R., Krause-Boehm, A., Meindl, A., Argani, P., Healey, J. H., Ueda, T., Yoshikawa, H., Meloni-Ehrig, A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204074 · Cited by 625 · cited 3×
“ASPL–TFE3 and PRCC–TFE3 fusion transcripts are detected readily by conventional reverse transcriptase polymerase chain reaction (RT-PCR) using appropriate primers, as described in detail elsewhere [10,11,17].”
BackgroundMethodSelf-citationKirchhausen, T. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.699 · Cited by 560
Widlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 371
Clark, J., Lu, Y.-J., Sidhar, S. K., Parker, C., Gill, S., Smedley, D., Hamoudi, R., Linehan, W. M., Shipley, J., & Cooper, C. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201394 · Cited by 344 · cited 2×
“At the molecular genetic level, TFE3 is a member of the basic-helix-loophelix family of transcription factors, whereas PSF and NonO are splicing factor genes [4].”
BackgroundArgani, P., Laé, M., Hutchinson, B., Reuter, V. E., Collins, M. H., Perentesis, J., Tomaszewski, J. E., Brooks, J. S. J., Acs, G., Bridge, J. A., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146007.54092.37 · Cited by 289 · cited 6×
“Only 9 cases have been reported in the literature [29–32], and the authors know of 1 unreported case.”
BackgroundSelf-citationMorphologic and Molecular Characterization of Renal Cell Carcinoma in Children and Young Adults
Bruder, E., Passera, O., Harms, D., Leuschner, I., Ladanyi, M., Argani, P., Eble, J. N., Struckmann, K., Schraml, P., & Moch, H. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000131558.32412.40 · Cited by 280 · cited 1×
“Using similar methods, Bruder et al [14] classified 8 of the 41 cases (20%) of renal carcinoma in children and young adults in their series as Xp11-translocation carcinomas.”
MethodSelf-citationSidhar, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.9.1333 · Cited by 272 · cited 1×
“2;q21), which fuses the PRCC and TFE3 genes (Table 1) [2,3].”
BackgroundA novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)
Argani, P., Lui, M. Y., Couturier, J., Bouvier, R., Fournet, J.-C., & Ladanyi, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206686 · Cited by 259
Self-citationDavis, I. J., Hsi, B.-L., Arroyo, J. D., Vargas, S. O., Yeh, Y. A., Motyckova, G., Valencia, P., Perez-Atayde, A. R., Argani, P., Ladanyi, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931430100 · Cited by 247
Self-citationArgani, P., Hawkins, A., Griffin, C. A., Goldstein, J. D., Haas, M., Beckwith, J. B., Mankinen, C. B., & Perlman, E. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64680-9 · Cited by 228 · cited 2×
“1 18/M [28,32] History of asthma; presents with hematuria after trauma 7 cm, left NED 18 months after nephrectomy”
BackgroundSelf-citationSteingrímsson, E., Tessarollo, L., Pathak, B., Hou, L., Arnheiter, H., Copeland, N. G., & Jenkins, N. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072071099 · Cited by 227
Kuiper, R. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg178 · Cited by 208
Weterman, M. A. J., Wilbrink, M., & van Kessel, A. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15294 · Cited by 206
Weterman, M. A. J., van Groningen, J. J. M., Jansen, A., & van Kessel, A. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203255 · Cited by 79 · cited 1×
“PRCC–TFE3 [21,24] and ASPL–TFE3 fusion proteins (M.”
Heimann, P., Housni, H. E., Oğur, G., Weterman, M. A. J., Petty, E. M., & Vassart, G. (2001) · PubMed · Cited by 77
Weterman, M. A. J., van Groningen, J. J. M., Tertoolen, L. G. J., & van Kessel, A. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241304198 · Cited by 76 · cited 1×
“PRCC–TFE3 also may interfere with splicing and mitotic checkpoint control by way of protein–protein interactions [21,25].”
BackgroundVerastegui, C., Bertolotto, C., Bille, K., Abbe, P., Ortonne, J. P., & Ballotti, R. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.3.0428 · Cited by 73
Skalsky, Y., Ajuh, P., Parker, C., Lamond, A. I., Goodwin, G. H., & Cooper, C. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204056 · Cited by 71 · cited 3×
“PRCC–TFE3 [21,24] and ASPL–TFE3 fusion proteins (M.”
BackgroundDiagnostic Utility of Microphthalmia Transcription Factor in Malignant Melanoma and Other Tumors
Chang, K. L., & Folpe, A. L. (2001) · Advances in Anatomic Pathology · doi:10.1097/00125480-200109000-00004 · Cited by 67 · cited 1×
“Nuclear labeling for MiTF is a sensitive and specific diagnostic immunohistochemical marker of melanocytic lesions and lesions in the perivascular epithelioid cell family, such as angiomyolipoma and lymphangioleiomyomatosis [33].”
BackgroundArgani, P., & Ladanyi, M. (2003) · Pathology · doi:10.1080/00313020310001619901 · Cited by 66
Self-citationClathrin: anatomy of a coat protein
Smith, C. J., & Pearse, B. M. F. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01631-1 · Cited by 53 · cited 1×
“The clathrin heavy chain gene (CLTC) trimerizes with a single light chain to form clathrin, the major protein constituent of the coat that surrounds organelles (cytoplasmic vesicles) to mediate selective protein transport [22,23].”
BackgroundVerastegui, C. (2000) · Molecular Endocrinology · doi:10.1210/me.14.3.449 · Cited by 19
Cited by
Immunohistochemical Diagnosis of Renal Neoplasms
Truong, L. D., & Shen, S. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0478-rar.1 · Cited by 337
Tsuda, M., Davis, I. J., Argani, P., Shukla, N., McGill, G. G., Nagai, M., Saito, T., Laé, M., Fisher, D. E., & Ladanyi, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2855 · Cited by 306
Self-citationUncommon and recently described renal carcinomas
Srigley, J. R., & Delahunt, B. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.70 · Cited by 209
Tu, J. J., Rohan, S., Kao, J., Kitabayashi, N., Mathew, S., & Chen, Y.-T. (2007) · Modern Pathology · doi:10.1038/modpathol.3800903 · Cited by 170
Metadata
- Authors
- Argani, P., & Ladanyi, M.
- Venue
- Clinics in Laboratory Medicine
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 25
- Issue
- 2
- Pages
- 363-378
- ISSN
- 0272-2712 (ISSN-L)
- OpenAlex
- W2133908084
- Cited by
- 236
- References
- 25
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.